Opening of testing lab ushers in a new era of targeted treatments to change glioblastoma diagnosis from terminal to treatable
DURHAM, NC / ACCESSWIRE / August 29, 2024 / The Glioblastoma Foundation is hosting a welcome ceremony to inaugurate its innovative Genomic Testing & Research Laboratory, a first-of-its-kind lab in the U.S. The cutting-edge laboratory is set to revolutionize the fight against glioblastoma by offering patients access to advanced genomic testing and personalized drug identification. Attendees will have a first-hand opportunity to tour the state-of-the-art lab, meet the team behind this groundbreaking initiative, and learn about the future of tailored glioblastoma treatment. The Lab aims to provide crucial, low-cost testing services and faster turnaround to enhance outcomes and improve quality of life for glioblastoma patients.
WHAT: To mark the opening of the Genomic Testing & Research Laboratory, the Glioblastoma Foundation is hosting informational speakers and a guided tour of the Lab and testing equipment.
WHO: Oncologists, neurologists, researchers, patients and their families, the media, and anyone else interested in leading the fight against the most aggressive form of brain cancer are welcome.
WHERE: The Chesterfield Building, 701 W. Main St., Suite 200, Durham, NC 27701
WHEN: Tuesday, September 3, 2024; 10:00 AM – 2:00 PM
Scheduled activities
10:00 AM – 10:15 AM Registration & Refreshments
10:15 AM – 10:30 AM Welcoming Remarks, Gita Kwatra, PharmD, MBA CEO, Glioblastoma Foundation, Durham, NC
10:35 AM – 10:55 PM Glioblastoma Diagnosis & Surgery, Christopher Jackson, MD, Assistant Professor, Dept of Neurosurgery Johns Hopkins University, Baltimore, MD
11:00 AM – 11:20 AM Postsurgical Management of Glioblastoma Patients, Glenn Lesser, MD, Professor & Deputy Director, Atrium Health Wake Forest Baptist, Comprehensive Cancer Center Wake Forest University Medical Center, Winston-Salem, NC
11:25 AM – 11:45 AM Mission of the Personalized Medicine Coalition (PMC), Christopher Wells, MPA, Senior Vice President for Public Affairs, PMC, Washington, DC
11:50 AM – 12:00 PM Ribbon-Cutting Ceremony
12:00 PM – 1:00 PM Catered Lunch
1:00 PM – 2:00 PM Guided Lab Tours
DETAILS: RSVP By August 29, 2024, to Sydney Carmer at sydney@glioblastomafoundation.org
For more information about the Glioblastoma Foundation, visit https://glioblastomafoundation.org/
###
About the Glioblastoma Foundation: Established in 2016, the Glioblastoma Foundation aims to transform glioblastoma treatment and care through research, advocacy, and support initiatives. By funding innovative research projects, raising awareness, and providing resources for patients and families, the Foundation strives to improve outcomes and quality of life for those affected by this aggressive form of brain cancer. Initiatives such as the Genomic Testing & Research Laboratory will allow the Foundation to transform glioblastoma from a terminal cancer to a treatable one within the next five years. For more information about the Glioblastoma Foundation, please visit https://www.glioblastomafoundation.org.
Contact Information
Sydney Carmer
Video Journalist
sydney@glioblastomafoundation.org
919-402-1775
SOURCE: Glioblastoma Foundation, Inc.
View the original press release on newswire.com.
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…
